In The News

November 12, 2021
FRIDAY, Nov. 12, 2021 (HealthDay News) -- Despite concerns about his close ties to the drug industry, President Joe Biden is expected on Friday to nominate Dr. Robert Califf, former head of the U.S.…
November 12, 2021
The White House tapped cardiologist Robert Califf, MD, to once again head the FDA. In a statement formally announcing his decision, President Biden praised Califf's clinical research expertise and…
November 12, 2021
President Joe Biden’s nomination of former FDA chief Robert Califf to once again lead the agency aims to bring a familiar face back to FDA at a critical juncture as the agency gears up for a post-…
November 12, 2021
After months of speculation – and just days before a statutory deadline – President Joe Biden on Friday announced he would nominate Robert Califf to serve as Commissioner of Food and Drugs for the…
November 12, 2021
WASHINGTON — President Biden announced on Friday that he would nominate Dr. Robert M. Califf, a former commissioner of the Food and Drug Administration, to lead the agency again. His decision ends…
November 12, 2021
Robert Califf was nominated Friday by President Joe Biden to run the U.S. Food and Drug Administration, a move that is likely to put a one-time commissioner back at the health agency’s helm in the…
November 12, 2021
President Biden on Friday nominated former Food and Drug Administration commissioner Robert M. Califf to return as the agency’s head, ending a difficult, months-long search to find a leader for the…
November 12, 2021
President Joe Biden has nominated former Commissioner Robert Califf to lead the Food and Drug Administration Friday, in a move that would bring the Obama-era official back for a second tour atop the…
November 10, 2021
Friends of Cancer Research is calling on all stakeholders in the cancer community to move away from the idea of “more is better” in drug dosing and begin to incorporate dose-finding studies into the…
November 9, 2021
A newly released white paper from the Friends of Cancer Research calls for a collaborative effort to investigate the use of circulating tumor DNA (ctDNA) as an “early endpoint” to predict long-term…